Revolution Medicines (RVMD) Payables (2018 - 2025)
Historic Payables for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to $74.8 million.
- Revolution Medicines' Payables rose 20605.58% to $74.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.8 million, marking a year-over-year increase of 20605.58%. This contributed to the annual value of $54.4 million for FY2024, which is 1191.33% down from last year.
- As of Q3 2025, Revolution Medicines' Payables stood at $74.8 million, which was up 20605.58% from $56.8 million recorded in Q2 2025.
- Revolution Medicines' 5-year Payables high stood at $74.8 million for Q3 2025, and its period low was $9.6 million during Q1 2021.
- For the 5-year period, Revolution Medicines' Payables averaged around $30.5 million, with its median value being $24.5 million (2024).
- In the last 5 years, Revolution Medicines' Payables crashed by 1745.37% in 2024 and then soared by 20605.58% in 2025.
- Revolution Medicines' Payables (Quarter) stood at $14.1 million in 2021, then surged by 51.57% to $21.3 million in 2022, then surged by 190.0% to $61.8 million in 2023, then dropped by 11.91% to $54.4 million in 2024, then soared by 37.52% to $74.8 million in 2025.
- Its Payables was $74.8 million in Q3 2025, compared to $56.8 million in Q2 2025 and $47.5 million in Q1 2025.